Innovation & The Economy: Beyond the Headlines

Seattle-based A-Alpha Bio just launched Atlas, a platform that doesn't just design drugs with AI, but generates the massive datasets needed to make AI work.

Hyliion's appointment of defense guru Abdul Subhani isn't just a new hire; it's a calculated move to secure a central role in military energy resilience.

WellSpan Health's integration with a top local oncology practice promises better care through tech and scale. But does this move signal a brighter future for patients or a troubling trend of market consolidation?

Beyond a single contract, Performance Shipping's new three-year deal with Aramco reveals a masterclass in de-risking against market volatility.

RP1's Artemis, the first native metaverse browser, challenges tech giants with an open-source engine designed to end the era of walled-garden spatial experiences.

TD Bank consolidates its commercial divisions under Jill Gateman, signaling a strategic shift toward a deeply integrated client model and an AI-driven future.

A South Korean biotech's diabetes drug finds new purpose in fighting FSHD, backed by a foundation's innovative funding model that could reshape rare disease R&D.

For the fourth year, a Tennessee buffet has ranked among America's best. But its true success lies in a 60-year-old recipe blending tradition with community.

Waste Pro's latest $150M bond deal isn't just about money; it's a look into the financial engine driving a private company's rapid southeastern expansion.

A new deal brings wood-based vanillin to North America, promising to solve the vanilla bean's notorious volatility with a stable, sustainable alternative.

A surge in biotech innovation is set to transform the high-grade glioma market. With a pipeline of targeted drugs and vaccines, a once-stagnant field is now a beacon of hope.

A data intelligence firm just swapped its founding CEO for a Pentagon veteran. It’s not a shake-up; it’s a calculated move to conquer the high-stakes world of defense tech.

Top execs at Cuentas are buying stock ahead of a 'Bitcoin Mobile' launch, signaling big confidence. But a closer look reveals a high-stakes gamble.

As AI's insatiable demand for memory creates a multi-year supply bottleneck, a new ETF offers a 'pure play' bet on the handful of companies dominating production.

As prediction markets go mainstream, the tech behind them is critical. We look at Connamara's award-winning EP3 and how it's shaping the future of trading.

A new 48-unit development in an affluent Chicago suburb offers more than just housing; it provides a replicable model for tackling a regional crisis.

Intensity Therapeutics shows promising results for its cancer-killing drug, but can it navigate the biotech funding crunch and land a vital pharma partner?

The university that gave football the huddle now partners with Nike. This historic deal is more than gear—it's a strategic play for visibility and inclusion.

Seven years in, the CROWN Act has changed laws in 30 states. But as Dove's new campaign shows, the battle against hair discrimination is far from over.

QDM International's 179% revenue jump is stunning, but soaring costs and a pivot to AI reveal the high-stakes game of survival in Hong Kong's new economy.